CN1385537A - 一种用代谢工程菌生产腺苷甲硫氨酸的方法 - Google Patents
一种用代谢工程菌生产腺苷甲硫氨酸的方法 Download PDFInfo
- Publication number
- CN1385537A CN1385537A CN 02112087 CN02112087A CN1385537A CN 1385537 A CN1385537 A CN 1385537A CN 02112087 CN02112087 CN 02112087 CN 02112087 A CN02112087 A CN 02112087A CN 1385537 A CN1385537 A CN 1385537A
- Authority
- CN
- China
- Prior art keywords
- sam
- fermentation
- gene
- adenosylmethionine
- expression plasmid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 title claims abstract description 70
- 241000894006 Bacteria Species 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims description 16
- 238000012269 metabolic engineering Methods 0.000 title claims description 4
- 238000000855 fermentation Methods 0.000 claims abstract description 40
- 230000004151 fermentation Effects 0.000 claims abstract description 40
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 33
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 29
- 102000003960 Ligases Human genes 0.000 claims abstract description 24
- 108090000364 Ligases Proteins 0.000 claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 claims abstract description 19
- 241000235058 Komagataella pastoris Species 0.000 claims abstract description 14
- 101150028074 2 gene Proteins 0.000 claims abstract description 12
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract description 10
- 230000033228 biological regulation Effects 0.000 claims abstract description 7
- 229930182817 methionine Natural products 0.000 claims abstract description 6
- 238000004321 preservation Methods 0.000 claims abstract description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 45
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 27
- 239000013613 expression plasmid Substances 0.000 claims description 15
- 108010084455 Zeocin Proteins 0.000 claims description 8
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 239000013598 vector Substances 0.000 claims description 5
- 239000013604 expression vector Substances 0.000 claims description 3
- 230000009466 transformation Effects 0.000 claims description 2
- 101710088194 Dehydrogenase Proteins 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 229960004452 methionine Drugs 0.000 abstract description 8
- 230000001580 bacterial effect Effects 0.000 abstract description 5
- 210000004027 cell Anatomy 0.000 description 31
- 108090000623 proteins and genes Proteins 0.000 description 13
- 239000002609 medium Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 238000004520 electroporation Methods 0.000 description 7
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 7
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- LXJXRIRHZLFYRP-UHFFFAOYSA-N glyceraldehyde 3-phosphate Chemical compound O=CC(O)COP(O)(O)=O LXJXRIRHZLFYRP-UHFFFAOYSA-N 0.000 description 6
- 210000005253 yeast cell Anatomy 0.000 description 6
- 239000001888 Peptone Substances 0.000 description 5
- 108010080698 Peptones Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000019319 peptone Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000003259 recombinant expression Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 101710194180 Alcohol oxidase 1 Proteins 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 239000008057 potassium phosphate buffer Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 3
- 229930195722 L-methionine Natural products 0.000 description 3
- 101150021948 SAM2 gene Proteins 0.000 description 3
- 239000013592 cell lysate Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000013611 chromosomal DNA Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 231100000693 bioaccumulation Toxicity 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 230000036983 biotransformation Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000007222 ypd medium Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 102100026115 S-adenosylmethionine synthase isoform type-1 Human genes 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 210000001728 clone cell Anatomy 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108010027322 single cell proteins Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
步骤 | 温度 | 时间 | 循环数 |
起始变性 | 94℃ | 5min | 1 |
变性 | 94℃ | 30sec | 5 |
退火 | 42℃ | 30sec | |
延伸 | 72℃ | 3min | |
变性 | 94℃ | 30sec | 30 |
退火 | 55℃ | 1min | |
延伸 | 72℃ | 3min | |
最后延伸 | 72℃ | 10min | 1 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021120870A CN1191369C (zh) | 2002-06-14 | 2002-06-14 | 一种用代谢工程菌生产腺苷甲硫氨酸的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021120870A CN1191369C (zh) | 2002-06-14 | 2002-06-14 | 一种用代谢工程菌生产腺苷甲硫氨酸的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1385537A true CN1385537A (zh) | 2002-12-18 |
CN1191369C CN1191369C (zh) | 2005-03-02 |
Family
ID=4741889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021120870A Expired - Fee Related CN1191369C (zh) | 2002-06-14 | 2002-06-14 | 一种用代谢工程菌生产腺苷甲硫氨酸的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1191369C (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1308457C (zh) * | 2003-03-06 | 2007-04-04 | 电化学工业有限公司(国际) | 发酵生产s-腺苷甲硫氨酸的方法 |
CN101012470B (zh) * | 2007-01-25 | 2010-06-16 | 华东理工大学 | 一种发酵生产s-腺苷甲硫氨酸的方法 |
CN101392230B (zh) * | 2008-01-07 | 2012-05-23 | 北京凯因科技股份有限公司 | 一株表达腺苷蛋氨酸合成酶的重组大肠埃希氏菌 |
CN102559726A (zh) * | 2010-12-31 | 2012-07-11 | 华东理工大学 | Gap启动子文库在调节s-腺苷甲硫氨酸代谢途径中的应用 |
CN1916176B (zh) * | 2006-09-11 | 2012-07-18 | 中国科学院上海生命科学研究院 | 一种体外酶催化合成腺苷甲硫氨酸的方法 |
CN101676384B (zh) * | 2008-09-16 | 2013-02-06 | 浙江升华拜克生物股份有限公司 | 一种同时高产谷胱甘肽和s-腺苷甲硫氨酸的方法 |
CN109957556A (zh) * | 2019-03-15 | 2019-07-02 | 自然资源部第三海洋研究所 | 一种s-腺苷甲硫氨酸的制备方法 |
CN115058350A (zh) * | 2022-04-28 | 2022-09-16 | 广西大学 | 一种引入钾离子转运体提高s-腺苷甲硫氨酸产量的方法 |
CN117802142A (zh) * | 2024-02-05 | 2024-04-02 | 苏州华赛生物工程技术有限公司 | 一种生产SAMe的基因工程酵母菌株及其生产SAMe的方法 |
CN118109540A (zh) * | 2024-03-20 | 2024-05-31 | 苏州华赛生物工程技术有限公司 | 一种提高SAMe产量的方法 |
-
2002
- 2002-06-14 CN CNB021120870A patent/CN1191369C/zh not_active Expired - Fee Related
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1308457C (zh) * | 2003-03-06 | 2007-04-04 | 电化学工业有限公司(国际) | 发酵生产s-腺苷甲硫氨酸的方法 |
CN1916176B (zh) * | 2006-09-11 | 2012-07-18 | 中国科学院上海生命科学研究院 | 一种体外酶催化合成腺苷甲硫氨酸的方法 |
CN101012470B (zh) * | 2007-01-25 | 2010-06-16 | 华东理工大学 | 一种发酵生产s-腺苷甲硫氨酸的方法 |
CN101392230B (zh) * | 2008-01-07 | 2012-05-23 | 北京凯因科技股份有限公司 | 一株表达腺苷蛋氨酸合成酶的重组大肠埃希氏菌 |
CN101676384B (zh) * | 2008-09-16 | 2013-02-06 | 浙江升华拜克生物股份有限公司 | 一种同时高产谷胱甘肽和s-腺苷甲硫氨酸的方法 |
CN102559726B (zh) * | 2010-12-31 | 2013-10-09 | 华东理工大学 | Gap启动子文库在调节s-腺苷甲硫氨酸代谢途径中的应用 |
CN102559726A (zh) * | 2010-12-31 | 2012-07-11 | 华东理工大学 | Gap启动子文库在调节s-腺苷甲硫氨酸代谢途径中的应用 |
CN109957556A (zh) * | 2019-03-15 | 2019-07-02 | 自然资源部第三海洋研究所 | 一种s-腺苷甲硫氨酸的制备方法 |
CN109957556B (zh) * | 2019-03-15 | 2021-06-04 | 自然资源部第三海洋研究所 | 一种s-腺苷甲硫氨酸的制备方法 |
CN115058350A (zh) * | 2022-04-28 | 2022-09-16 | 广西大学 | 一种引入钾离子转运体提高s-腺苷甲硫氨酸产量的方法 |
CN115058350B (zh) * | 2022-04-28 | 2023-12-01 | 湖南成大生物科技有限公司 | 一种引入钾离子转运体提高s-腺苷甲硫氨酸产量的方法 |
CN117802142A (zh) * | 2024-02-05 | 2024-04-02 | 苏州华赛生物工程技术有限公司 | 一种生产SAMe的基因工程酵母菌株及其生产SAMe的方法 |
CN118109540A (zh) * | 2024-03-20 | 2024-05-31 | 苏州华赛生物工程技术有限公司 | 一种提高SAMe产量的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1191369C (zh) | 2005-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN117683802B (zh) | 一种通过甲基苹果酸途径生产异亮氨酸的罗尔斯通氏菌工程菌株及其构建与生产方法 | |
US9328358B2 (en) | Method of producing 2, 3-butanediol using recombinant yeast | |
CN1191369C (zh) | 一种用代谢工程菌生产腺苷甲硫氨酸的方法 | |
WO2022174597A1 (zh) | 一种用于l-肌氨酸生产的基因工程菌及构建方法与应用 | |
CN111394288B (zh) | 重组谷氨酸棒杆菌、其构建方法及其生产四氢嘧啶的方法 | |
CN105950529A (zh) | 产3-羟基丙酸的重组谷氨酸棒杆菌、其构建方法及应用 | |
CN116064345A (zh) | 高效生产岩藻糖基乳糖的无抗基因工程菌及其应用 | |
CN117327636A (zh) | 一种产o-琥珀酰-l-高丝氨酸的基因工程菌、构建方法及应用 | |
CN117511831A (zh) | 产麦角硫因的大肠杆菌的构建方法 | |
CN101012470A (zh) | 一种发酵生产s-腺苷甲硫氨酸的方法 | |
US10619174B2 (en) | Microorganism strains for the production of 2.3-butanediol | |
JP6343754B2 (ja) | 耐酸耐塩性付与方法と耐酸耐塩性酵母を用いた有用物質生産 | |
CN108102941A (zh) | 一株含特定膜结合甘油脱氢酶基因序列的氧化葡萄糖酸杆菌及其应用 | |
CN117126792A (zh) | 一种用于生产l-茶氨酸的重组质粒、基因工程菌株及方法 | |
CN1916176B (zh) | 一种体外酶催化合成腺苷甲硫氨酸的方法 | |
CN114874961B (zh) | 一种利用乙醛合成乙偶姻的重组运动发酵单胞菌及其构建方法与应用 | |
CN113249281B (zh) | 一种利用乙醇生产间苯三酚的重组菌及其构建方法与应用 | |
WO2023246071A1 (zh) | 一种mreC突变体及其在L-缬氨酸发酵生产中的应用 | |
CN116179380A (zh) | 一种高产丙酮酸的解脂耶氏酵母工程菌wsmhp、构建方法及应用 | |
CN106566856B (zh) | 提高s-腺苷蛋氨酸和谷胱甘肽发酵产量的方法 | |
JP2024513194A (ja) | 副産物の生成が低減した2,3-ブタンジオール生産用の組換え微生物、及びこれを用いる2,3-ブタンジオールの生産方法 | |
CN118931747A (zh) | 高效合成肌醇的马克斯克鲁维酵母工程菌及其应用 | |
CN118006645A (zh) | 一种喜盐芽孢杆菌来源的四氢嘧啶基因簇、突变体及应用 | |
CN115896153A (zh) | 一种利用重组谷氨酸棒杆菌代谢甘露醇发酵提高l-鸟氨酸产量的方法 | |
CN118048285A (zh) | 一种稳定生产l-甲硫氨酸的基因工程菌及其构建方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI INST. OF LIFE SCIENCE, CAS Free format text: FORMER OWNER: INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY, SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES, CHINESE ACADEMY OF SCIENCES Effective date: 20090619 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090619 Address after: No. 320, Yueyang Road, Shanghai Patentee after: Shanghai Institute of life Sciences, Chinese Academy of Sciences Address before: No. 320, Yueyang Road, Shanghai Patentee before: Inst. of Biochemistry and Cell Biology, Shanghai Research Academy of Life Scienc |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050302 Termination date: 20160614 |
|
CF01 | Termination of patent right due to non-payment of annual fee |